Sagard ^Investors

25%+ Portfolio average annual revenue growth Our strategy Sagard NewGen makes majority or minority investments between 10M€ and 50M€ (excluding co-investors), with or without leverage, to finance expansion strategies of tech and healthcare, Europe-based companies with revenues up to 150M€, that are already profitable. Learn more NewGen Team